Implants of carotid body cells as a treatment alternative for Parkinson disease
Departamento de Neurología y Neurocirugía, Clínica Universitaria, Facultad de Medicina, Universidad de Navarra, Pamplona, Navarra.
Magazine: Revista de Medicina de la Universidad de Navarra
Date: Apr 1, 2001Neurology [SP]
The appearance of motor fluctuations and dyskinesias in a large number of parkinsonian patients treated with levodopa, has promoted the development of new therapeutical approaches. Deep brain stimulation of subthalamic nucleus and globus pallidus medialis results in a marked improvement of parkinsonism and levodopa-induced dyskinesias. However, this approach does no delay the progression of the disease.
Transplantation of dopamine-releasing cells might represent an advantage as these cells could replace the loss of dopaminergic neurons occurring in Parkinson's disease. This article reviews the main results obtained in experimental models of Parkinson's disease and in humans using different types of dopaminergic cells. The advantages and limitations of this treatment are also discussed.
CITATION Rev Med Univ Navarra. 2001 Apr-Jun;45(2):49-54
you maybe interested
The Clínica is the greater private hospital with technological equipment of Spain, all in a single center.
The professionals of the Clínica perform continuous research and training, always to the benefit of the patient.
Learn why we are different from other healthcare centers. Quality, speed, comfort and results.